Literature DB >> 19494052

N-linked glycans on dengue viruses grown in mammalian and insect cells.

Kari Hacker1, Laura White, Aravinda M de Silva.   

Abstract

This study compared the ability of mosquito and mammalian cell-derived dengue virus (DENV) to infect human dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN)-expressing cells and characterized the structure of envelope (E) protein N-linked glycans on DENV derived from the two cell types. DENVs derived from both cell types were equally effective at infecting DC-SIGN-expressing human monocytes and dendritic cells. The N-linked glycans on mosquito cell-derived virus were a mix of high-mannose and paucimannose glycans. In virus derived from mammalian cells, the N-linked glycans were a mix of high-mannose and complex glycans. These results indicate that N-linked glycans are incompletely processed during DENV egress from cells, resulting in high-mannose glycans on viruses derived from both cell types. Studies with full-length and truncated E protein demonstrated that incomplete processing was most likely a result of the poor accessibility of glycans on the membrane-anchored protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494052      PMCID: PMC2887570          DOI: 10.1099/vir.0.012120-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  57 in total

Review 1.  Flavivirus structure and membrane fusion.

Authors:  Franz X Heinz; Steven L Allison
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

2.  Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.

Authors:  N L Davis; I J Caley; K W Brown; M R Betts; D M Irlbeck; K M McGrath; M J Connell; D C Montefiori; J A Frelinger; R Swanstrom; P R Johnson; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Prospects for a dengue virus vaccine.

Authors:  Stephen S Whitehead; Joseph E Blaney; Anna P Durbin; Brian R Murphy
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

5.  Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera.

Authors:  T J Chambers; D W McCourt; C M Rice
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

Review 6.  Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases.

Authors:  F Maley; R B Trimble; A L Tarentino; T H Plummer
Journal:  Anal Biochem       Date:  1989-08-01       Impact factor: 3.365

7.  Human skin Langerhans cells are targets of dengue virus infection.

Authors:  S J Wu; G Grouard-Vogel; W Sun; J R Mascola; E Brachtel; R Putvatana; M K Louder; L Filgueira; M A Marovich; H K Wong; A Blauvelt; G S Murphy; M L Robb; B L Innes; D L Birx; C G Hayes; S S Frankel
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

8.  An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.

Authors:  Laura J White; Melissa M Parsons; Alan C Whitmore; Brandon M Williams; Aravinda de Silva; Robert E Johnston
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

9.  DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses.

Authors:  William B Klimstra; Elizabeth M Nangle; M Shane Smith; Andrew D Yurochko; Kate D Ryman
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus.

Authors:  Thomas Gramberg; Heike Hofmann; Peggy Möller; Patricia F Lalor; Andrea Marzi; Martina Geier; Mandy Krumbiegel; Thomas Winkler; Frank Kirchhoff; David H Adams; Stephan Becker; Jan Münch; Stefan Pöhlmann
Journal:  Virology       Date:  2005-09-30       Impact factor: 3.616

View more
  37 in total

1.  Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling.

Authors:  Aleksandra A Watson; Andrey A Lebedev; Benjamin A Hall; Angharad E Fenton-May; Alexei A Vagin; Wanwisa Dejnirattisai; James Felce; Juthathip Mongkolsapaya; Angelina S Palma; Yan Liu; Ten Feizi; Gavin R Screaton; Garib N Murshudov; Christopher A O'Callaghan
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

2.  Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis.

Authors:  Derek L Carbaugh; Ralph S Baric; Helen M Lazear
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

3.  Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.

Authors:  Kouki Morizono; Amy Ku; Yiming Xie; Airi Harui; Sam K P Kung; Michael D Roth; Benhur Lee; Irvin S Y Chen
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

Review 4.  Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis.

Authors:  Nanda Kishore Routhu; Siddappa N Byrareddy
Journal:  J Neuroimmune Pharmacol       Date:  2017-03-27       Impact factor: 4.147

Review 5.  Flavivirus Envelope Protein Glycosylation: Impacts on Viral Infection and Pathogenesis.

Authors:  Derek L Carbaugh; Helen M Lazear
Journal:  J Virol       Date:  2020-05-18       Impact factor: 5.103

6.  Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin.

Authors:  Anja Fuchs; Tsai-Yu Lin; David W Beasley; Cordula M Stover; Wilhelm J Schwaeble; Theodore C Pierson; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2010-08-19       Impact factor: 21.023

Review 7.  Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design.

Authors:  Max Crispin; Katie J Doores
Journal:  Curr Opin Virol       Date:  2015-03-06       Impact factor: 7.090

8.  Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion.

Authors:  Steinar Halldorsson; Anna-Janina Behrens; Karl Harlos; Juha T Huiskonen; Richard M Elliott; Max Crispin; Benjamin Brennan; Thomas A Bowden
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

9.  Dengue virus entry as target for antiviral therapy.

Authors:  Marijke M F Alen; Dominique Schols
Journal:  J Trop Med       Date:  2012-03-04

10.  High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.

Authors:  Wen-Yang Tsai; Chih-Yun Lai; Yi-Chieh Wu; Hong-En Lin; Carolyn Edwards; Amonrat Jumnainsong; Srisakul Kliks; Scott Halstead; Juthathip Mongkolsapaya; Gavin R Screaton; Wei-Kung Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.